Delivery Order SPE2DB20D1100-SPE2DB25FC6U0
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 1, 2025, for the supply of Eliquis 5 mg tablets (60-count packaging) valued at $2,635.82. This competitively awarded, firm fixed-price delivery order is scheduled for completion by May 2, 2025, with performance to be executed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger pharmaceutical supply vehicle...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a contract ceiling value of $55,353.92. This competitively awarded, firm fixed-price delivery order is scheduled for completion by June 20, 2025, and represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the federal government. The work will be performed at the company's corporate office...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 14, 2025, for the supply of Eliquis 5 mg tablets (60-count units) at a firm fixed price ceiling value of $25,069.77. This non-set-aside, competitively awarded contract is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on July 10, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) with a ceiling value of $27,309.78. This firm fixed-price delivery order is scheduled for completion by July 11, 2025, and will be fulfilled from the contractor's location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets in quantities of 60 units, with a ceiling value of $16,480.94. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The contract is scheduled for ultimate completion by September 9, 2025, and performance will occur at AmerisourceBergen's corporate office location in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 14, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $11,416.41. This firm fixed-price delivery order is non-competitive and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a total value of $999,999,999.00 through December 2026. The work is to be performed at AmerisourceBergen's...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 8, 2025, for the supply of Eliquis 5 mg tablets (60-count) with a ceiling value of $21,218.77. This competitively awarded, firm fixed-price delivery order is set to be completed by September 9, 2025, and will be fulfilled from the vendor's Conshohocken, Pennsylvania facility. The contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on May 12, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $4,306.19. This firm fixed-price delivery order is set to be completed by May 13, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a non-competitive delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract with DLA Troop...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $3,931.20. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through open competition. The contract is set for ultimate completion on July 29, 2025, with performance to be fulfilled at the awardee's facility in Conshohocken, Pennsylvania. This delivery order represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Eliquis 5 mg tablets (60-count packages) valued at $25,897.33. This non-set-aside, competitively awarded contract represents a firm fixed-price delivery order with an ultimate completion date of July 25, 2025. The award is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a comprehensive pharmaceutical supply...
- SPE2DB20D1100Indefinite Delivery Contract
- SPE2DB20D1100-SPE2DB25FC6U0Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for the supply of Eliquis 5 mg tablets (60-count units) with a ceiling value of $49,357.52. This firm fixed-price delivery order, which is expected to be completed by June 4, 2025, represents a child contract under AmerisourceBergen's larger indefinite delivery contract with DLA Troop Support Medical. The award was made through open competition with no set-aside designation, reflecting the contractor's demonstrated capability to meet federal pharmaceutical procurement requirements. Performance will be executed from the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp serves as a critical pharmaceutical distributor for federal medical procurement, with an extensive portfolio of delivery orders through the Defense Logistics Agency's Medical Supply Chain. The company holds a significant $999,999,999 indefinite delivery contract with DLA Troop Support Medical through December 2026, which enables it to supply a broad range of pharmaceuticals and medical supplies to support military healthcare programs globally. This delivery order for Eliquis, an anticoagulant medication, exemplifies the company's role in providing essential brand-name pharmaceuticals to the Department of Defense healthcare systems.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $49.4k | 6/3/25 |